Topics: Antineoplastic Agents, chemotherapy, Antineoplastic Agents, Treatment-induced tumor, Cancer chemotherapeutic agents, cell cycle, Cell-cycle non specific agents, Cell-cycle specific agents, Hormone therapy, hormone antagonists, Endocrine therapy, Corticosteroids, Estrogens, Progestons, Goserelin Acetate, gonadotropin, GnRH analogues, gonadotropin-releasing hormone, tamoxifen, SELECTIVE ESTROGEN RECEPTOR MODULATORS, breast cancer, Tamoxifen Raloxifen Torimefene, ANTI ESTROGENS, FULVESTRANT, SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR, AROMATASE INHIBITORS, Letrozole, Anastrazole, Exemestane, LHRH AGONISTS, Leuprolide, Goserelin, PROGESTINS, Megestrol acetate, Medroxyprogesterone acetate, prostrate cancer